Literature DB >> 30099750

Pathogen infections and primary biliary cholangitis.

A Tanaka1, P S C Leung2, M E Gershwin2.   

Abstract

Primary biliary cholangitis (PBC) is a multi-factorial disease caused by the interaction of both genetic predisposition and environmental triggers. Bacterial infection has been investigated most intensively, both epidemiologically and experimentally, as a prime environmental aetiology in PBC. The association of recurrent history of urinary tract infection (UTI) with PBC has been frequently confirmed by several large-scale, case-control studies, despite variation in geographic area or case-finding methods. Escherichia coli is a predominant pathogen in most cases with UTI. Animal studies and molecular mimicry analysis between the human and E. coli E2 subunit of the 2-oxo-acid dehydrogenase complexes demonstrated that E. coli infection is a key factor in breaking immunological tolerance against the mitochondria, resulting in the production of anti-mitochondrial autoantibodies (AMA), the disease-specific autoantibodies of PBC. Novosphingobium aromaticivorans, a ubiquitous xenobiotic-metabolizing bacterium, is another candidate which may be involved in the aetiology of PBC. Meanwhile, improved environmental hygiene and increased prevalence of PBC, especially in males, may argue against the aetiological role of bacterial infection in PBC. Multiple mechanisms can result in the loss of tolerance to mitochondrial autoantigens in PBC; nonetheless, bacterial infection is probably one of the dominant pathways, especially in female patients. Notably, there is a rising prevalence of male patients with PBC. With increasing exposure to environmental xenobiotics in both genders, studies directed towards identifying the environmental culprit with systematically designed case-control studies are much needed to further determine the environmental factors and role of bacterial infections in PBC.
© 2018 British Society for Immunology.

Entities:  

Keywords:  zzm321990Escherichia colizzm321990; zzm321990Novosphingobium aromaticivoranszzm321990; anti-mitochondrial autoantibodies; molecular mimicry; pyruvate dehydrogenase E2 subunit; urinary tract infection

Mesh:

Substances:

Year:  2018        PMID: 30099750      PMCID: PMC6300644          DOI: 10.1111/cei.13198

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  92 in total

1.  The geographical distribution of primary biliary cirrhosis in a well-defined cohort.

Authors:  M I Prince; A Chetwynd; P Diggle; M Jarner; J V Metcalf; O F James
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

2.  Primary biliary cirrhosis showing a high titer of autoantibody; report of a case.

Authors:  I R MACKAY
Journal:  N Engl J Med       Date:  1958-01-23       Impact factor: 91.245

3.  Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis.

Authors:  Christophe Corpechot; Yves Chrétien; Olivier Chazouillères; Raoul Poupon
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

Review 4.  Environmental basis of primary biliary cholangitis.

Authors:  Atsushi Tanaka; Patrick Sc Leung; M Eric Gershwin
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

Review 5.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

6.  Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality.

Authors:  A N Hamlyn; A F Macklon; O James
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

Review 7.  Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.

Authors:  Yu-Qing Xie; Hong-Di Ma; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

8.  No specific association between primary biliary cirrhosis and bacteriuria?

Authors:  A Floreani; M F Bassendine; H Mitchison; R Freeman; O F James
Journal:  J Hepatol       Date:  1989-03       Impact factor: 25.083

9.  Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis.

Authors:  J Van de Water; A Ansari; T Prindiville; R L Coppel; N Ricalton; B L Kotzin; S Liu; T E Roche; S M Krams; S Munoz; M E Gershwin
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase.

Authors:  J Van de Water; M E Gershwin; P Leung; A Ansari; R L Coppel
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Authors:  Timur Liwinski; Melina Heinemann; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2022-05-10       Impact factor: 11.759

2.  Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions.

Authors:  Meng-Na Wang; Hai-Tao Yu; Ya-Qian Li; Yun Zeng; Shuang Yang; Guo-Ping Yang; Qi Pei; Jie Huang
Journal:  Drug Des Devel Ther       Date:  2021-01-14       Impact factor: 4.162

3.  Genetic association of E26 transformation specific sequence 1 polymorphisms with the susceptibility of primary biliary cholangitis in China.

Authors:  Huan Xu; Qian Niu; Zhenzhen Su; Fang Wang; Junlong Zhang; Bin Yang; Zhuochun Huang
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

Review 4.  Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.

Authors:  Aleksandar Arsenijevic; Bojana Stojanovic; Jelena Milovanovic; Dragana Arsenijevic; Nebojsa Arsenijevic; Marija Milovanovic
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

5.  Autoantibodies to speckled protein family in primary biliary cholangitis.

Authors:  Alessandro Granito; Luigi Muratori; Francesco Tovoli; Paolo Muratori
Journal:  Allergy Asthma Clin Immunol       Date:  2021-03-31       Impact factor: 3.406

Review 6.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

7.  Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM.

Authors:  Marlene Plüß; Désirée Tampe; Harald Schwörer; Sebastian Christopher Benjamin Bremer; Björn Tampe
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

8.  Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.

Authors:  Isabell Nilsson; Jeremy Palmer; Eirini Apostolou; Carl-Gerhard Gottfries; Muhammad Rizwan; Charlotte Dahle; Anders Rosén
Journal:  Front Med (Lausanne)       Date:  2020-03-31

9.  Autoantibodies associated with primary biliary cholangitis are common among patients with systemic lupus erythematosus even in the absence of elevated liver enzymes.

Authors:  A Ahmad; R Heijke; P Eriksson; L Wirestam; S Kechagias; C Dahle; C Sjöwall
Journal:  Clin Exp Immunol       Date:  2020-09-29       Impact factor: 4.330

10.  The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic.

Authors:  Longxian Lv; Huiyong Jiang; Xiaoxiao Chen; Qiangqiang Wang; Kaicen Wang; Jianzhong Ye; Yating Li; Daiqiong Fang; Yingfeng Lu; Liya Yang; Silan Gu; Jianing Chen; Hongyan Diao; Ren Yan; Lanjuan Li
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.